Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
361
-
Total 13F shares, excl. options
-
42.7M
-
Shares change
-
-83.5K
-
Total reported value, excl. options
-
$5B
-
Value change
-
-$6.69M
-
Put/Call ratio
-
1.21
-
Number of buys
-
168
-
Number of sells
-
-154
-
Price
-
$117.37
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2019
414 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2019.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 361 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.7M shares
of 44.8M outstanding shares and own 95.25% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.99M shares), VANGUARD GROUP INC (3.96M shares), FMR LLC (2.69M shares), AQR CAPITAL MANAGEMENT LLC (2.49M shares), RENAISSANCE TECHNOLOGIES LLC (2.24M shares), STATE STREET CORP (2.22M shares), Palo Alto Investors LP (1.63M shares), FIRST TRUST ADVISORS LP (1.29M shares), Consonance Capital Management LP (1.23M shares), and DIMENSIONAL FUND ADVISORS LP (1.07M shares).
This table shows the top 361 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.